EDGAR B BASSIG
Allopathic & Osteopathic Physicians|Internal Medicine LOCKPORT, NY NPI 1205891306
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine NY Lilly USA, LLC All categories
General Payments — all program years on this page
$11,003.40
- Category: General Payments
- Program years: PY2018–2024
- Record count: 746
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,406.63 across 75 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,406.63 | 75 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $295.62 | 11 |
| Amgen Inc. | $245.39 | 13 |
| Novo Nordisk AS | $175.19 | 12 |
| GlaxoSmithKline, LLC. | $90.18 | 5 |
| Phathom Pharmaceuticals, Inc. | $63.35 | 4 |
| Acerta Pharma LLC | $52.77 | 3 |
| Seqirus USA Inc | $50.36 | 2 |
| DEXCOM, INC. | $50.24 | 3 |
| PFIZER INC. | $49.49 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $47.11 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $43.59 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $41.84 | 3 |
| Insulet Corporation | $32.48 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $31.21 | 2 |
| Mylan Specialty L.P. | $29.17 | 2 |
| Amneal Pharmaceuticals LLC | $20.40 | 1 |
| IBSA Pharma Inc. | $20.06 | 1 |
| Astellas Pharma US Inc | $19.11 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $18.48 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.71 | 1 |
| Exact Sciences Corporation | $14.88 | 1 |
By program year
Records — PY2024 (75)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.